InvestorsHub Logo
Followers 154
Posts 2653
Boards Moderated 0
Alias Born 01/29/2004

Re: JWC3 post# 275351

Tuesday, 10/13/2020 9:05:45 AM

Tuesday, October 13, 2020 9:05:45 AM

Post# of 464087
They'll know.

One should always consult with their certified investment advisor before making any changes in their portfolio.


Yea, all those investment advisors that know the details of cellular biology and neuron cytology are gonna be really helpful in allowing AVXL shareholders to understand the mechanisms of action (MOAs) of the company's sigma-1 receptor agonists. Call one of those guys. Ask to learn the role of endoplasmic reticular folding of peptides into functioning enzymes, homeostatically controlled by genetically-moderated feedback cascades, pathways, etc.

If the Anavex MOAs don't work, a bad investment. If they do (which is the case), just the opposite.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News